TELA Bio (TELA) Director Joseph H. Capper Buys Stock

What Happened
Joseph H. Capper, a director of TELA Bio, reported two purchases (transaction code P) totaling 75,000 shares. On 2026-09-14 he acquired 25,000 shares (reported price $1.02; total $25,503) and on 2026-09-15 he acquired 50,000 shares (reported price $1.06; total $52,940), for an aggregate outlay of approximately $78,443. These were reported as open-market or private purchases and are purchases (often regarded as a more informative signal than sales).

Key Details

• Transaction dates and reported prices:
  • 2026-09-14: 25,000 shares, reported $1.02 (total $25,503). Footnote F1: weighted-average, actual prices ranged $0.9899–$1.04.
  • 2026-09-15: 50,000 shares, reported $1.06 (total $52,940). Footnote F2: weighted-average, actual prices ranged $1.01–$1.10.
• Total shares purchased: 75,000; total reported cost: ~$78,443.
• Shares owned after transaction: not disclosed in the Form 4 provided.
• Filing timeliness: Report filed 2026-09-16 covering transactions on 9/14 and 9/15; appears timely (Form 4 is generally due within two business days).
• No options, gifts, or tax-withholding events reported in these entries.

Context
These entries are straightforward purchases (P). Footnotes explain the reported prices are weighted averages across multiple trades; the filer has offered to provide a breakdown of individual trade prices on request. Purchases by directors can be of interest to investors but do not by themselves prove future performance—this is factual reporting of insider buying activity.